Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats

CRSP:   |  Region:   |  Topic:   |  Database:

E. Afriyie-Gyawu; J. Mackie; B. Dash; M. Wiles; J. Taylor; H. Huebner; L. Tang; H. Guan; J.-S. Wang; T.D. Phillips

Type of Document:
Scholarly Article


Food Additives and Contaminants

Date of Publication:

Place of Publication:
Not Available


Abstract: NovaSil (NS) clay, a common anti-caking agent in animal feeds, has been shown to sorb aflatoxins in the GI tract and diminish their bioavailability and adverse effects in short-term animal studies. Based on this evidence, it is hypothesized that clay-based enterosorption of aflatoxins may be a useful strategy for the prevention of aflatoxicosis in human populations. However, the potential toxicity of long-term dietary exposure to NS has not been determined. In this research, 5-6-week-old male and female Sprague-Dawley rats were fed rations containing 0, 0.25, 0.5, 1.0, or 2.0% (w/w) levels of NS for 28 weeks. Analysis of the NS showed negligible levels of dioxin and furan contaminants. Total feed consumption, cumulative feed consumption, body weight, total body weight gain, feed conversion efficiency, cumulative feed conversion efficiency, and relative organ weights were unaffected in either sex at the doses tested. No NS-dependent differences in relative organ weights or gross or histopathological changes were observed. Analysis of hematological parameters, clinical chemistry, and selected vitamin and mineral levels revealed isolated significant differences between some treatments and control groups (mean corpuscular hemoglobin, serum Ca, serum vitamin A, and serum Fe). However, the differences observed in each case were not dose-dependent. These results suggest that dietary inclusion of NS at levels as high as 2.0% (w/w) does not result in overt toxicity. These findings (as well as others) support the use of NS clay for dietary intervention studies in human populations at high risk for aflatoxicosis.

Additional Bibliographic Information

Coming soon

Send us your questions or comments

Your Name (required)

Your Email (required)


Please enter this text: